LON:CIZ Cizzle Biotechnology (CIZ) Share Price, News & Analysis GBX 1.90 +0.20 (+11.76%) (As of 11/21/2024 ET) Add Share Share Stock Analysis Stock AnalysisChartDividendHoldings About Cizzle Biotechnology (LON:CIZ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cizzle Biotechnology alerts:Sign Up Key Stats Today's Range 1.78▼ 1.9950-Day Range 1.75▼ 2.2352-Week Range 1.42▼ 3.38Volume932,918 shsAverage Volume1.24 million shsMarket Capitalization£7.53 millionAssets Under Management£48.98 millionDividend Yield3.45%Net Expense Ratio0.46%Aggregate RatingN/A ETF OverviewCizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.Read More… Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.58%0.55%0.45%0.52%Other Expenses0.25%0.30%0.49%0.25%0.53%Total Expense0.66%0.65%0.71%0.54%0.71%Fee Waiver-0.20%-0.26%-0.52%-0.20%-0.57%Net Expense0.46%0.62%0.61%0.47%0.59% Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address CIZ ETF News HeadlinesCizzle partners with Moffitt Cancer Center for early lung cancer detectionSeptember 13, 2024 | msn.comCIZZLE BIOTECHNOLOGY ANNOUNCES GROUNDBREAKING COLLABORATION WITH MOFFITT CANCER CENTER TO ADVANCE EARLY-STAGE LUNG CANCER DETECTIONSeptember 12, 2024 | finance.yahoo.comJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.November 21, 2024 | Priority Gold (Ad)Cizzle Biotechnology Holdings PLCApril 26, 2024 | wsj.comCizzle Biotechnology Holdings Plc (CIZ.L)January 6, 2024 | finance.yahoo.comMurphy Canyon to hold meeting on planned buy of interest in AZD1656August 15, 2023 | lse.co.ukSee More Headlines CIZ ETF - Frequently Asked Questions How have CIZ shares performed this year? Cizzle Biotechnology's stock was trading at GBX 1.95 at the beginning of the year. Since then, CIZ shares have decreased by 2.6% and is now trading at GBX 1.90. View the best growth stocks for 2024 here. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Cizzle Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Preferred Apartment Communities (APTS) and Baidu (BIDU). Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com Phone44-20-3934-6630Fund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9,243.20 Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares396,390,000Beta0.38 Creation Unit50,000 Creation Fee$4,500.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Top 5 CIZ HoldingsFederated Treasury Obligations FundHolding Weight: 99.98%EVRAZ PLCHolding Weight: 0.02%China Common Rich RenHolding Weight: 0.00%Constellation Software InHolding Weight: 0.00%Prudential PlcHolding Weight: 0.00%Full Holdings DetailsCIZ Sector ExposureCIZ Industry Exposure This page (LON:CIZ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cizzle Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CIZ Stock Alerts